Pregnancy Related Clinical Trial
Official title:
Evaluating the Impact of Emergency Maternity Housing on Mother and Child Well-being, Housing, and Employment
Moms will call and agencies will determine if she is eligible based on basic criteria. If she is eligible, the agency will send her an intake application link to complete, which includes a consent form. After completing the survey, if she is still eligible, she will be placed on a waitlist for services. When a bed becomes available in an individual agency, the agency will call two moms at the top of the waitlist, conduct in-person interviews to confirm eligibility and good fit. They will use a computer to randomly assign one to treatment and one to control. Agency will let moms know of their status and will allow the treatment mom to move in. Moms in treatment and control will be surveyed approximately one year post the mother's reported due date of the child.
Status | Recruiting |
Enrollment | 1048 |
Est. completion date | December 1, 2025 |
Est. primary completion date | December 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Each home has their own eligibility criteria. The main three criteria common across homes are that a woman must be at least 18 years old, experiencing housing instability, and pregnant. No home has an income standard because, by definition, applicants are in a precarious housing situation so most women are low-income. Each home does have slightly different eligibility criteria. For example, some homes allow other children to come with her into the home, while other homes do not. Some homes require a background check and might allow a woman to enter the home anyway depending on the prior offense. Exclusion Criteria: - Women who are not pregnant, men, pregnant women under 18, some homes exclude mothers who have other children currently in their care |
Country | Name | City | State |
---|---|---|---|
United States | University of Notre Dame | Notre Dame | Indiana |
Lead Sponsor | Collaborator |
---|---|
University of Notre Dame | Aid for Women, Bethlehem House, In My Shoes, Maggie's Place, USA, Our Lady's Inn, USA |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in rates of self-reported taking baby to term between treatment and control groups | The research team will use self-reported rates of taking the baby to term between treatment and control groups | 1 year after approximate due date of baby | |
Primary | Difference in rates of self-reported retaining custody of baby between treatment and control groups | The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported retaining custody of the baby | 1 year after approximate due date of baby | |
Primary | Difference in rates of self-reported loneliness and depression between treatment and control groups | The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported loneliness and depression levels. | 1 year after approximate due date of baby | |
Primary | Difference in rates of self-reported life satisfaction between treatment and control groups | The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported life satisfaction | 1 year after approximate due date of baby | |
Primary | Difference in rates of self-reported sense of self-efficacy between treatment and control groups | The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported sense of self-efficacy | 1 year after approximate due date of baby | |
Primary | Difference in housing stability between treatment and control groups | The research team will use self-reported independent living status and whether the mom has a mortgage or lease in her own name at the time of follow to quantify the impact of receiving a bed in the maternity home on housing stability. | 1 year after approximate due date of baby | |
Primary | Difference in rates of continuum of care utilization between treatment and control groups | The research team will use mother's interactions with other local service agencies involved in the locality's continuum of care system to quantify the impact of receiving a bed in the maternity home on continuum of care interactions. | 1 year after approximate due date of baby | |
Primary | Difference in employment rates between treatment and control groups | The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported employment. | 1 year after approximate due date of baby | |
Primary | Difference in safety-net utilization rates between treatment and control groups | The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported amount of welfare received, for example TANF, WIC, SNAP, etc. | 1 year after approximate due date of baby | |
Primary | Difference in education rates between treatment and control groups | The research team will use survey data to quantify the impact of receiving a bed in the maternity home on self-reported education level. | 1 year after approximate due date of baby | |
Secondary | Difference in housing stability between treatment and control groups | The research team will explore using information from Infutor Data Solutions to also capture address changes and will compare these findings with the self-reported information about housing. Infutor data will only be an exploratory outcome. | 1 year after approximate due date of baby |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 |